title: Regulation of differentiation of sheep subcutaneous and abdominal preadipocytes in culture.
abstract: Factors regulating the differentiation of sheep subcutaneous and abdominal (omental or perirenal) preadipocytes from foetal lambs, suckling lambs and fattening sheep have been investigated using a serum-free cell culture system. Differentiation was assessed by changes in the activity of the enzyme glycerol 3-phosphate dehydrogenase. Insulin or IGF-I was essential for differentiation. Dexamethasone, a lipid supplement (Excyte) and the thiazolidinedione, rosiglitazone (BRL 49653) (a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist) all enhanced preadipocyte differentiation, whereas fibroblast growth factor and GH were inhibitory. The most effective combination was insulin, triiodothyronine, dexamethasone and rosiglitazone. Under suboptimal conditions, preadipocytes from fattening sheep differentiated less well than cells from suckling and foetal lambs. Also, under suboptimal conditions, abdominal preadipocytes did not differentiate as well as subcutaneous preadipocytes. However, age and depot differences were minimised when cells were cultured with insulin, triiodothyronine, rosiglitazone and either dexamethasone or lipid. The results suggest that variation in the ability to produce the natural ligand for PPAR-gamma contributes to depot- and age-specific differences in the ability of preadipocytes to differentiate.
authors.affiliation: Hannah Research Institute, Ayr KA6 5HL, UK.
authors.forename: B
authors.initials: B
authors.lastname: Soret
authors.forename: H J
authors.initials: HJ
authors.lastname: Lee
authors.forename: E
authors.initials: E
authors.lastname: Finley
authors.forename: S C
authors.initials: SC
authors.lastname: Lee
authors.forename: R G
authors.initials: RG
authors.lastname: Vernon
mesh_terms: D000005:Abdomen; D000273:Adipose Tissue / Q000166:cytology* / Q000187:drug effects; D000818:Animals; D000833:Animals, Suckling; D002417:Cattle; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology*; D005260:Female; D005346:Fibroblast Growth Factors / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D013006:Growth Hormone / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D011247:Pregnancy; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists*; D000077154:Rosiglitazone; D012756:Sheep; D013844:Thiazoles / Q000494:pharmacology*; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000819:agonists*; D014284:Triiodothyronine / Q000494:pharmacology
chemical_list: D005938:Glucocorticoids; D007328:Insulin; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077154:Rosiglitazone; D014284:Triiodothyronine; D005346:Fibroblast Growth Factors; D003907:Dexamethasone; D013006:Growth Hormone